Cargando…
Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors
The breast cancer resistance protein (BCRP) is an ABC transporter playing a crucial role in the pharmacokinetics of drugs. The early identification of substrates and inhibitors of this efflux transporter can help to prevent or foresee drug-drug interactions. In this work, we built a ligand-based in...
Autores principales: | Montanari, Floriane, Cseke, Anna, Wlcek, Katrin, Ecker, Gerhard F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302078/ https://www.ncbi.nlm.nih.gov/pubmed/27401583 http://dx.doi.org/10.1177/1087057116657513 |
Ejemplares similares
-
Databases, DrugBank, and virtual screening platforms for therapeutic development
por: Middha, Sushil Kumar, et al.
Publicado: (2022) -
DrugBank 5.0: a major update to the DrugBank database for 2018
por: Wishart, David S, et al.
Publicado: (2018) -
Subtle Structural Differences Trigger Inhibitory Activity of Propafenone Analogues at the Two Polyspecific ABC Transporters: P‐Glycoprotein (P‐gp) and Breast Cancer Resistance Protein (BCRP)
por: Schwarz, Theresa, et al.
Publicado: (2016) -
DrugBank: a knowledgebase for drugs, drug actions and drug targets
por: Wishart, David S., et al.
Publicado: (2008) -
Evaluating drug-drug interaction information in NDF-RT and DrugBank
por: Peters, Lee B, et al.
Publicado: (2015)